INZY Inozyme Pharma Inc

USD 4.88 0.14 2.953586
Icon

Inozyme Pharma Inc (INZY) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.88

+0.14 (+2.95)%

USD 0.28B

0.35M

USD 17.50(+258.61%)

N/A

Icon

INZY

Inozyme Pharma Inc (USD)
COMMON STOCK | NSD
USD 4.88
0.00 0
Take a Tour

Inozyme Pharma Inc (INZY) Stock Forecast

Show ratings and price targets of :
USD 17.50
(+258.61%)

Based on the Inozyme Pharma Inc stock forecast from 3 analysts, the average analyst target price for Inozyme Pharma Inc is USD 17.50 over the next 12 months. Inozyme Pharma Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Inozyme Pharma Inc is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Inozyme Pharma Inc’s stock price was USD 4.88. Inozyme Pharma Inc’s stock price has changed by +10.41% over the past week, -23.87% over the past month and -17.15% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...